Characteristic | CAD (n = 65) | Non-CAD (n = 55) | P values |
---|---|---|---|
Age (yrs) | 64.9 ± 10.6* | 59.1 ± 9.6 | < 0.05 |
Sex (F/M) | 13/52* | 26/29 | < 0.05 |
SBP (mmHg) | 132 ± 22 | 129 ± 19 | 0.238 |
DBP (mmHg) | 81 ± 14 | 77 ± 12 | 0.163 |
Body mass index (kg/m2) | 26.6 ± 3.3 | 25.9 ± 4.8 | 0.835 |
Waist-to-hip ratio | 0.85 ± 0.10 | 0.83 ± 0.15 | 0.729 |
Fasting plasma glucose (mg/dl) | 103.3 ± 12.3 | 101.7 ± 13.3 | 0.527 |
Impaired fasting glucose [n (%)] | 35 (53.9%) | 30 (54.5%) | 0.938 |
HbA1C (%) | 5.4 ± 0.9 | 5.2 ± 0.7 | 0.725 |
Family history of CAD [n (%)] | 12 (18.4%) | 8 (14.5%) | 0.815 |
Past history [n (%)] | Â | Â | Â |
   Hypercholesterolemia | 34 (52.3) | 28 (51.0) | 0.078 |
   Hypertension | 47 (72.3) | 37 (67.2) | 0.159 |
   Alcohol intake | 22 (33.8) | 22 (40.0) | 0.875 |
   Current smoker | 18 (27.7) | 14 (25.4) | 0.753 |
Lipid profiles (mg/dL) | Â | Â | Â |
   Total cholesterol | 215 ± 48 | 208 ± 41 | 0.238 |
   LDL cholesterol | 127 ± 37 | 119 ± 42 | 0.105 |
   HDL cholesterol | 41 ± 10 | 43 ± 12 | 0.369 |
   Triglycerides | 217 ± 126 | 209 ± 138 | 0.245 |
Concomitant medication [n (%)] | Â | Â | Â |
   Aspirin/Clopidogrel | 37 (56.9) | 25 (45.4) | 0.095 |
   β Adrenergic blockers | 18 (27.7) | 16 (29.1) | 0.358 |
   Calcium channel blockers | 44 (67.7) | 36 (65.4) | 0.259 |
   ACE inhibitor/ARB | 29 (44.6) | 23 (41.8) | 0.347 |
   Diuretics | 24 (36.9) | 18 (32.7) | 0.135 |
   Statin | 33 (50.8) | 26 (47.2) | 0.085 |
   Fibrate | 5 (7.7) | 4 (7.3) | 0.468 |